Ingenza Ltd. has recently received funding from the Technology Strategy Board for three new biotechnology projects in the areas of Industrial Biotechnology and the commercial application of high-throughput genome sequencing. These projects will directly support and accelerate Ingenza’s synthetic biology platforms to manufacture high value chemicals, biologicals and biofuels. The role of the Technology Strategy Board is to promote and support research, development and exploitation of technology and innovation for the benefit of UK business, to increase economic growth and improve the quality of life.

Ingenza Ltd., is a leader in the development and application of engineered microbes for industrial use, operating state-of-the-art facilities at The Roslin BioCentre, on the outskirts of Edinburgh. Ingenza’s team has over 25 years of expertise in molecular genetics, enzymology, fermentation and bioprocess development. The company’s high cell density fermentation and industrial bioprocesses are currently undergoing scale-up worldwide.

Dr Ian Fotheringham, President of Ingenza, commented; “Technology Strategy Board support is a key driver of innovation in UK biotechnology and I am thrilled that we have been awarded this funding to expand the industrial applicability of our production organisms”.

Dr Franck Escalettes, Head of Biosciences at Ingenza added; “High-throughput genome sequencing is extremely synergistic with our strain improvement programs, enabling us to rapidly identify the basis of improved performance and to combine random and rational mutation approaches.”

The awards will further enhance Ingenza’s position at the forefront of industrial and synthetic biotechnology worldwide.

Notes to editiors

Ingenza Ltd

Ingenza Ltd, located in Edinburgh, UK, is the biocatalyst and bioprocess development unit of Richmond Chemical Corporation. Since its inception in 2003, Ingenza has established a worldwide customer base and platforms for the proprietary technologies to manufacture chiral compounds, proteins and high value chemicals.

Ingenza’s scientific and commercial team draws upon a history of success in applied biocatalysis and the development of technology and products for the fine chemical, food and pharmaceutical industries. Ingenza offers tailored microbes and biocatalytic solutions on a client specific basis and applies its enabling technologies in strain construction for the manufacture of biopharmaceuticals, bioprocess optimization and the enhancement of microbes used in the production of biofuels.


Technology Strategy Board

The Technology Strategy Board is a business-led government body which works to create economic growth by ensuring that the UK is a global leader in innovation. Sponsored by the Department for Business, Innovation and Skills (BIS), the Technology Strategy Board brings together business, research and the public sector, supporting and accelerating the development of innovative products and services to meet market needs, tackle major societal challenges and help build the future economy. For more information please visit: Technology Strategy Board website